ARDX$3.030.00%0.00
Pre-market: 3.01-0.02 -0.66%
Ardelyx Inc (ARDX)
Date: 2026-11-02 16:00O: 2.99H: 3.09L: 2.98C: 3.03Vol: 4.612M
Ardelyx Inc stock is traded at $3.03, with a volume of 4,612,220. It is up 0.00% in the last 24 hours and down -9.28% over the past month. Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Previous Close:
$3.03
Open:
$2.99
24h Volume:
4,612,220
Relative Volume:
1.18
Market Cap:
$782.31M
Revenue:
$427.68M
Net Income/Loss:
-$58.06M
P/E Ratio:
-
EPS:
-$0.2382
Net Cash Flow:
-$37.50M
1W Performance:
+1.00%
1M Performance:
-9.28%
6M Performance:
-55.96%
1Y Performance:
-48.82%
1-Day Range:
$0.00$0.00
1-Week Range:
$2.96$3.16
52-Week Range:
$2.96$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Name
Ardelyx IncSector
HealthcareIndustry
BiotechnologyPhone
510-745-7047Address
34175 ARDENWOOD BLVD., FREMONT, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
Ardelyx Inc Stock (ARDX) Financials Data
Ardelyx Inc Stock (ARDX) Insider Trading
- Foster Eric DuaneAug 21 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.03
- #Shares
- 11,900
- Value ($)
- 47,957
- #Shares Total
- 0
- Bishop John EAug 21 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.03
- #Shares
- 25,500
- Value ($)
- 102,765
- #Shares Total
- 0
- Brady James ParkerAug 21 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.03
- #Shares
- 19,700
- Value ($)
- 79,391
- #Shares Total
- 0
- Brady James ParkerAug 21 '26Chief Human Resources Officer
- Transaction
- Sale
- Cost
- $3.86
- #Shares
- 15,136
- Value ($)
- 58,378
- #Shares Total
- 245,930
- Foster Eric DuaneAug 21 '26Chief Commercial Officer
- Transaction
- Sale
- Cost
- $3.86
- #Shares
- 8,562
- Value ($)
- 33,023
- #Shares Total
- 409,410
- Kelliher MikeAug 21 '26Chief Business Officer
- Transaction
- Sale
- Cost
- $3.86
- #Shares
- 7,758
- Value ($)
- 29,922
- #Shares Total
- 349,660
- Williams Laura AAug 21 '26Chief Patient Officer
- Transaction
- Sale
- Cost
- $3.86
- #Shares
- 10,739
- Value ($)
- 41,419
- #Shares Total
- 367,456
- RAAB MICHAELAug 21 '26President & CEO
- Transaction
- Sale
- Cost
- $3.86
- #Shares
- 58,574
- Value ($)
- 225,914
- #Shares Total
- 1,619,792
- Hohenleitner SusanAug 21 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.03
- #Shares
- 2,650
- Value ($)
- 10,680
- #Shares Total
- 0
- Reilly Joseph JamesAug 21 '26See Remarks
- Transaction
- Sale
- Cost
- $3.86
- #Shares
- 3,982
- Value ($)
- 15,358
- #Shares Total
- 145,854
